Skip to main content
Home
Library
Publishing
About
Home
Library
Publishing
About
Jonathan Rankin
ID:
LEX-AR-M8VTGYZJ
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
1 articles
Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDA
Big Molecule Watch ·
March 5, 2024
cite